Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.
Poolchanuan P. et al, (2025), Scientific reports, 15
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.
Mellors J. et al, (2025), Nature communications, 16
Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry.
Arman BY. et al, (2025), NPJ vaccines, 10
Asparagine availability controls germinal center B cell homeostasis.
Yazicioglu YF. et al, (2024), Science immunology, 9
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Colton H. et al, (2024), British journal of haematology
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure (London, England : 1993), 32, 1594 - 1602.e6
COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review.
Galgut O. et al, (2024), Vaccine: X, 20
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam
Thanh TT. et al, (2024), International Journal of Infectious Diseases, 147, 107173 - 107173
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi M. et al, (2024), The Lancet, 404, 1199 - 1226
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection
Jindal J. et al, (2024), Metabolism, 156035 - 156035
Dysregulated immunologic landscape of the early host response in melioidosis.
Rongkard P. et al, (2024), JCI insight, 9
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Naghavi M. et al, (2024), The Lancet Infectious Diseases, 24, 868 - 895
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Lim YJ. et al, (2024), British journal of haematology, 205, 440 - 451
Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening.
Clarke R. et al, (2024), NPJ vaccines, 9
Implications of suboptimal measles immunity in UK health-care workers.
Ho A. et al, (2024), Lancet (London, England), 404, 23 - 24
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study
Jackson S. et al, (2024), The Lancet Microbe, 5, 655 - 668
Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.
Peerawaranun P. et al, (2024), Diabetic medicine : a journal of the British Diabetic Association
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS. et al, (2024), The Lancet. Rheumatology, 6, e339 - e351
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553